Discure Technologies Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Discure Technologies General Information

Description

Developer of a minimally invasive implant designed to treat degenerative disc disease (DDD). The company develops a minimally invasive implantable bioelectronic device designed to reduce the use of opioids and the need for invasive back surgery by actively controlling the reintroduction of fluid, oxygen and nutrients into the degenerated disc, enabling doctors to eliminate pain and restore the disc's standard functionality.

Contact Information

Website
www.discuremd.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 61 Jabotinsky Street
  • BSR Towers, Building C
  • Petach-Tikva 4959220
  • Israel
+972
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Surgical Devices
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • 61 Jabotinsky Street
  • BSR Towers, Building C
  • Petach-Tikva 4959220
  • Israel
+972

Discure Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Discure Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 04-Mar-2025 Completed Clinical Trials - General
4. Later Stage VC (Series A) 10-Sep-2024 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jun-2022 Completed Pre-Clinical Trials
2. Seed Round 11-Apr-2022 $5M $7.1M Completed Pre-Clinical Trials
1. Seed Round $2.1M $2.1M Completed Startup
To view Discure Technologies’s complete valuation and funding history, request access »

Discure Technologies Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A
To view Discure Technologies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Discure Technologies Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Discure Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003228083-A1 Joint and dental implants Inactive 23-May-2002
AU-2003228083-A8 Joint and dental implants Inactive 23-May-2002
WO-2003099156-A2 Joint and dental implants Inactive 23-May-2002
WO-2003099156-A3 Joint and dental implants Inactive 23-May-2002
AU-2003206104-A1 Joint prostheses Inactive 24-Jan-2002 A61F2/30767
To view Discure Technologies’s complete patent history, request access »

Discure Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Discure Technologies Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Food and Drug Administration Government
K2X Venture Capital Minority
Sanara Capital Venture Capital Minority
Supernova Invest Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
You’re viewing 5 of 11 investors. Get the full list »

Discure Technologies Investments (3)

Discure Technologies’s most recent deal was a Later Stage VC with NUsurface for . The deal was made on 09-Sep-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NUsurface 09-Sep-2013 Later Stage VC Therapeutic Devices
NUsurface 02-Dec-2009 Later Stage VC Therapeutic Devices
NUsurface 31-Jul-2007 Early Stage VC Therapeutic Devices
To view Discure Technologies’s complete investments history, request access »

Ready to get started?

Request a free trial

Discure Technologies FAQs

  • When was Discure Technologies founded?

    Discure Technologies was founded in 2019.

  • Where is Discure Technologies headquartered?

    Discure Technologies is headquartered in Petach-Tikva, Israel.

  • What is the size of Discure Technologies?

    Discure Technologies has 13 total employees.

  • What industry is Discure Technologies in?

    Discure Technologies’s primary industry is Therapeutic Devices.

  • Is Discure Technologies a private or public company?

    Discure Technologies is a Private company.

  • What is Discure Technologies’s current revenue?

    The current revenue for Discure Technologies is .

  • How much funding has Discure Technologies raised over time?

    Discure Technologies has raised $23.1M.

  • Who are Discure Technologies’s investors?

    U.S. Food and Drug Administration, K2X, Sanara Capital, Supernova Invest, and MedTech Innovator are 5 of 11 investors who have invested in Discure Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process